4 Results for "

Jak3 inhibitor I

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Jak3 inhibitor I" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-15508
CAS No.: 202475-60-3
Purity:  99.63%
Synonyms: WHI-P131; Jak3 inhibitor I
Target:  

JAK

Research Areas:  

Cancer

JANEX-1 (WHI-P131) is a potent and specific JAK3 inhibitor (estimated Ki=2.3 μM). JANEX-1 (WHI-P131) shows potent JAK3-inhibitory activity (IC50 of 78 μM), does not inhibit JAK1 and JAK2.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100849
CAS No.: 1918238-72-8
Target:  

JAK

Research Areas:  

Inflammation/Immunology

JAK3i is a highly selective JAK3 inhibitor (IC50: 0.43 nM). JAK3i forms a covalent bond with a cysteine in JAK3, but not the closely related kinase domains in JAK1, JAK2, or TYK2. JAK3i abolishes IL-2-driven T-cell proliferation in vivo and has the potential for  autoimmune disease research .
loading...
    loading...
Cat. No.: HY-159536
CAS No.: 1299417-07-4
Synonyms: KN-002; VR-588
Target:  

JAK

Research Areas:  

Inflammation/Immunology

Frevecitinib (KN-002; VR-588) is a lung-selective pan-JAKs (i.e., JAK1, JAK2, JAK3, TYK2) inhibitor. Frevecitinib reduces sputum eosinophil levels. Frevecitinib reduces fractional exhaled nitric oxide (FeNO) levels. Frevecitinib is used for the research of moderate-to-severe asthma .
loading...
    loading...
Cat. No.: HY-138222
CAS No.: 188829-39-2
Synonyms: WHI-P131 hydrochloride; Jak3 inhibitor I hydrochloride
Target:  

JAK

Research Areas:  

Cancer

JANEX-1 (WHI-P131) hydrochloride is a potent and specific JAK3 inhibitor (Ki=2.3 μM). JANEX-1 hydrochloride shows potent JAK3 inhibitory activity (IC50=78 μM), does not inhibit JAK1 and JAK2 .
loading...
    loading...